Doug Pyle

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Doug Pyle

Jun 6, 2024, 00:23 | Societies

Ophira Ginsburg: The best ASCO annual meeting I’ve been to yet

Quoting Ophira Ginsburg on LinkedIn: "It’s a wrap! Best American Society of Clinical Oncology (ASCO) annual meeting…

Feb 13, 2024, 18:37 | Blog

How ASCO’s Regional Councils Are Having an International Impact on Patients With Cancer - The ASCO Post

The ASCO Post made the following post on X: "How ASCO’s Regional Councils Are Having…

All: 2 Posts: 1 - 100

'

Dr. Manette Le Grange joins OncoDaily Editorial Board

'

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

'

New Paper Alert Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience

'

Highlights from TTLC2025

'

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023